ACVR1B and familial pancreatic carcinoma: Low ACVR1B expression was significantly associated with reduced recurrence-free survival in breast cancer patients (Fig. 1d) and with significantly decreased overall survival in pancreatic cancer patients (Fig. 1e, Supplementary Fig. 1a).